{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05139017",
            "orgStudyIdInfo": {
                "id": "2140-003"
            },
            "secondaryIdInfos": [
                {
                    "id": "VLS-101",
                    "type": "OTHER",
                    "domain": "Velos Bio"
                },
                {
                    "id": "MK-2140-003",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "waveLINE-003",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "2022-502646-27-00",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)",
            "officialTitle": "A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-study-of-zilovertamab-vedotin-mk-in-combination-with-standard-of-care-in-participants-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-rrdlbcl-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06-21",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-11",
            "studyFirstSubmitQcDate": "2021-11-29",
            "studyFirstPostDateStruct": {
                "date": "2021-12-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of zilovertamab vedotin (ZV) in combination with standard of care options for the treatment of rrDLBCL. This study will be divided into 2 parts: Dose Confirmation (Part 1) and Efficacy Expansion (Part 2) and will enroll participants who are at least 18 years of age with rrDLBCL. The hypotheses are: ZV in combination with rituximab, gemcitabine, and oxaliplatin (R-GemOx) is superior to R-GemOx with respect to progression-free survival (PFS) per Lugano response criteria by blinded independent review committee (BICR); and that ZV in combination with bendamustine rituximab (BR) is superior to BR with respect to PFS per Lugano response criteria by BICR.\n\nWith protocol amendment 4 (effective: 04-April-2024), enrollment in Cohort B (study arms Bendamustine Rituximab \\[BR\\] and ZV + BR) is discontinued. No efficacy outcome analysis and hypothesis testing will be conducted for Cohort B."
        },
        "conditionsModule": {
            "conditions": [
                "DLBCL",
                "Diffuse Large B-Cell Lymphoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "In Part 1, Dose Confirmation will be determined by modified toxicity probability interval (mTPI) design, where participants will be assigned to two treatment groups, cohort: A (zilovertamab vedotin in combinatio with R-GemOx) in parallel with cohort B (zilovertamab vedotin in combination with BR). Part 2 will be an Efficacy Expansion (cohorts A \\& B) where all participants in each cohort will be assigned to 2 treatment groups for the duration of the study.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 260,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ZV + R-GemOx (Part 1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this arm will receive doses of ZV (from 1.5 mg/Kg up to 2.5 mg/Kg) plus Rituximab 375 mg/m\\^2, Gemcitabine 1000 mg/m\\^2 and Oxaliplatin 100 mg/m\\^2 (R-GemOx) given intravenously on Day 1 of repeated 21-day cycles. Treatment will continue for up to 6 cycles.",
                    "interventionNames": [
                        "Biological: Zilovertamab vedotin",
                        "Biological: Rituximab",
                        "Drug: Gemcitabine",
                        "Drug: Oxaliplatin"
                    ]
                },
                {
                    "label": "ZV + R-GemOx (Part 2)",
                    "type": "EXPERIMENTAL",
                    "description": "Using the recommended Phase 2 dose (RP2D) dose of ZV plus R-GemOx from Part 1, participants will receive ZV plus R-GemOx given intravenously on Day 1 of repeated 21-day cycles. Treatment will continue for up to 6 cycles or until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Biological: Zilovertamab vedotin",
                        "Biological: Rituximab",
                        "Drug: Gemcitabine",
                        "Drug: Oxaliplatin"
                    ]
                },
                {
                    "label": "R-GemOx (active control for Part 2)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive R-GemOx given intravenously on Day 1 of repeated 21-day cycles. Treatment will continue for up to 6 cycles or until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Biological: Rituximab",
                        "Drug: Gemcitabine",
                        "Drug: Oxaliplatin"
                    ]
                },
                {
                    "label": "ZV + BR (Part 2)",
                    "type": "EXPERIMENTAL",
                    "description": "Using RP2D from Part 1, participants will receive ZV plus Rituximab 375 mg/m\\^2, given intravenously on Day 1 and Bendamustine 90 mg/m\\^2 given intravenously on Day 1 and 2, of repeated 21-day cycles. Treatment will continue for up to 6 cycles or until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Biological: Zilovertamab vedotin",
                        "Biological: Rituximab",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "Bendamustine Rituximab (BR)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive Rituximab 375 mg/m\\^2, given intravenously on Day 1 Bendamustine 90 mg/m\\^2 given intravenously on Day 1 and 2 of repeated 21-day cycles. Treatment will continue for up to 6 cycles or until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Biological: Rituximab",
                        "Drug: Bendamustine"
                    ]
                },
                {
                    "label": "ZV + BR (Part 1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this arm will receive doses of ZV (from 1.5 mg/Kg up to 2.5 mg/Kg) plus Rituximab 375 mg/m\\^2, Bendamustine 90 mg/m\\^2 (BR) given intravenously on Day 1 and 2 of repeated 21-day cycles. Treatment will continue for up to 6 cycles.",
                    "interventionNames": [
                        "Biological: Zilovertamab vedotin",
                        "Biological: Rituximab",
                        "Drug: Bendamustine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Zilovertamab vedotin",
                    "description": "Intravenous (IV) Infusion 1.5 mg/kg, 1.75 mg/kg, 2.0 mg/kg, 2.25 mg/kg, 2.5 mg/kg",
                    "armGroupLabels": [
                        "ZV + BR (Part 1)",
                        "ZV + BR (Part 2)",
                        "ZV + R-GemOx (Part 1)",
                        "ZV + R-GemOx (Part 2)"
                    ],
                    "otherNames": [
                        "MK-2140",
                        "VLS-101"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Rituximab",
                    "description": "IV Infusion 375 mg/m\\^2",
                    "armGroupLabels": [
                        "Bendamustine Rituximab (BR)",
                        "R-GemOx (active control for Part 2)",
                        "ZV + BR (Part 1)",
                        "ZV + BR (Part 2)",
                        "ZV + R-GemOx (Part 1)",
                        "ZV + R-GemOx (Part 2)"
                    ],
                    "otherNames": [
                        "Rituxan\u00ae/mabthera",
                        "Truxima\u00ae (rituximab-abbs)",
                        "RUXIENCE\u00ae)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Gemcitabine",
                    "description": "IV Infusion 1000 mg/m\\^2",
                    "armGroupLabels": [
                        "R-GemOx (active control for Part 2)",
                        "ZV + R-GemOx (Part 1)",
                        "ZV + R-GemOx (Part 2)"
                    ],
                    "otherNames": [
                        "Gemzar\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oxaliplatin",
                    "description": "IV Infusion 100 mg/m\\^2",
                    "armGroupLabels": [
                        "R-GemOx (active control for Part 2)",
                        "ZV + R-GemOx (Part 1)",
                        "ZV + R-GemOx (Part 2)"
                    ],
                    "otherNames": [
                        "Eloxatin\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bendamustine",
                    "description": "IV Infusion 90 mg/m\\^2",
                    "armGroupLabels": [
                        "Bendamustine Rituximab (BR)",
                        "ZV + BR (Part 1)",
                        "ZV + BR (Part 2)"
                    ],
                    "otherNames": [
                        "Bendeka\u00ae",
                        "Treanda\u00ae",
                        "Belrapzo\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants who experienced dose-limiting toxicities (DLTs) in Part 1",
                    "description": "The CTCAE, Version 5.0 will be used to grade the severity of AEs in this study. DLTs will be reported for Part 1 of this study.",
                    "timeFrame": "Up to ~6 weeks"
                },
                {
                    "measure": "Number of participants who experienced an adverse event (AE)",
                    "description": "An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experienced an AE will be reported.",
                    "timeFrame": "Up to ~34 months"
                },
                {
                    "measure": "Number of participants who discontinued study treatment due to an AE",
                    "description": "An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinued study treatment due to an AE will be reported.",
                    "timeFrame": "Up to ~34 months"
                },
                {
                    "measure": "PFS",
                    "description": "PFS, defined as the time from randomization to the first documented disease progression per Lugano response criteria as assessed by BICR or death due to any cause, whichever occurs first will be presented.",
                    "timeFrame": "Up to ~27 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall survival (OS)",
                    "description": "OS, defined as the time from randomization to death due to any cause will be reported.",
                    "timeFrame": "Up to ~34 months"
                },
                {
                    "measure": "Objective response rate (ORR)",
                    "description": "ORR, defined as the percentage of participants who achieve a complete response (CR) or partial response (PR) per Lugano criteria as assessed by BICR will be presented.",
                    "timeFrame": "Up to ~19 months"
                },
                {
                    "measure": "Duration of response (DOR)",
                    "description": "DOR, defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first, will be reported.",
                    "timeFrame": "Up to ~27 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has a histologically confirmed diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL).\n* Has radiographically measurable DLBCL per the Lugano response criteria, as assessed locally by the investigator.\n* Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 within 7 days prior to study treatment initiation.\n* Has adequate organ function.\n* Is able to provide new or archival tumor tissue sample not previously irradiated.\n\nZilovertamab vedotin plus R-GemOx, or R-GemOx study arms:\n\n* Has relapsed or refractory DLBCL and is ineligible for or have failed autologous stem-cell transplant (ASCT) and have failed at least 1 line of prior therapy.\n* Has post-chimeric antigen receptor T (post-CAR-T) cell therapy failure or is ineligible for CAR-T cell therapy.\n\nNot applicable with protocol amendment 4: Zilovertamab vedotin plus Bendamustine Rituximab (BR), and Bendamustine Rituximab study arms:\n\n* Has relapsed or refractory DLBCL and is ineligible for or have failed ASCT and have failed at least 2 lines of prior therapy.\n* Has post-CAR-T therapy failure or is ineligible for CAR-T cell therapy.\n\nExclusion Criteria:\n\n* Not applicable with protocol amendment 4: Has history of transformation of indolent disease to DLBCL\n* Has received solid organ transplant at any time.\n* Has received a diagnosis of primary mediastinal B-cell lymphoma (PMBCL).\n* Has clinically significant (ie, active) cardiovascular disease or serious cardiac arrhythmia requiring medication.\n* Has ongoing graft-versus-host disease (GVHD) of any grade, or is receiving treatment for their GVHD.\n* Has pericardial effusion or clinically significant pleural effusion.\n* Has ongoing Grade \\>1 peripheral neuropathy.\n* Has a history of a second malignancy, unless potentially curative treatment has been completed with no evidence of malignancy for 2 years.\n* Has a demyelinating form of Charcot-Marie-Tooth disease.\n* Has contraindication to any of the study intervention components due to prior anaphylactic reaction.\n* Has received prior systemic anticancer therapy, including investigational agents within 4 weeks prior to the first dose of study intervention.\n* Has received prior radiotherapy within 4 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not require corticosteroids, and not have had radiation pneumonitis.\n* Has ongoing corticosteroid therapy.\n* Has received a live or live-attenuated vaccine within 30 days before the first dose of study intervention.\n* Is currently participating in or has participated in a study of an investigational agent or has used an investigational device within 4 weeks before the first dose of study intervention.\n* Has known active central nervous system (CNS) lymphoma involvement or active CNS involvement by lymphoma. Participants with prior CNS involvement are eligible if their CNS disease is in radiographic, cytological (for cerebrospinal fluid disease), and clinical remission.\n* Has an active infection requiring systemic therapy.\n* Has a known history of human immunodeficiency virus (HIV) infection.\n* Has a known active Hepatitis C virus infection.\n* Has a known psychiatric or substance abuse disorder that would interfere with the participant's ability to cooperate with the requirements of the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Innovative Clinical Research Institute ( Site 0122)",
                    "status": "COMPLETED",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90603",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0133)",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40207",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "502-629-3681"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Louisiana State University Health Sciences Center New Orleans ( Site 0134)",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "504-568-2345"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "University of Maryland ( Site 0123)",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "410-328-7996"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Dana-Farber Cancer Institute-Lymphoma ( Site 0111)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "617-632-2305"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Massachusetts Medical School ( Site 0119)",
                    "status": "RECRUITING",
                    "city": "Worcester",
                    "state": "Massachusetts",
                    "zip": "01655",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "774-455-4446"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.26259,
                        "lon": -71.80229
                    }
                },
                {
                    "facility": "St. Vincent Frontier Cancer Center-Research ( Site 0108)",
                    "status": "RECRUITING",
                    "city": "Billings",
                    "state": "Montana",
                    "zip": "59102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "406-238-6290"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.78329,
                        "lon": -108.50069
                    }
                },
                {
                    "facility": "Atlantic Health System ( Site 0116)",
                    "status": "RECRUITING",
                    "city": "Morristown",
                    "state": "New Jersey",
                    "zip": "07960",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "908-522-2043"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79677,
                        "lon": -74.48154
                    }
                },
                {
                    "facility": "New York Medical College ( Site 0113)",
                    "status": "RECRUITING",
                    "city": "Valhalla",
                    "state": "New York",
                    "zip": "10595",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "914-594-2150"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.07482,
                        "lon": -73.77513
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0156)",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "615-936-8422"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200)",
                    "status": "COMPLETED",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2M9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Beijing Cancer hospital ( Site 3000)",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "zip": "100142",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+8601088196698"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Chongqing University Cancer Hospital-Medical Oncology ( Site 3025)",
                    "status": "RECRUITING",
                    "city": "Chongqing",
                    "state": "Chongqing",
                    "zip": "400030",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+8613647633737"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.56278,
                        "lon": 106.55278
                    }
                },
                {
                    "facility": "Sun Yat-sen University Cancer Center-Internal Medicine ( Site 3001)",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "state": "Guangdong",
                    "zip": "510030",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+86-020-87343272"
                        }
                    ],
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Zhujiang Hospital ( Site 3002)",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "state": "Guangdong",
                    "zip": "510280",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+86-020-61643888"
                        }
                    ],
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Henan Cancer Hospital-hematology department ( Site 3013)",
                    "status": "RECRUITING",
                    "city": "Zhengzhou",
                    "state": "Henan",
                    "zip": "450008",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0371-65588007"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.75778,
                        "lon": 113.64861
                    }
                },
                {
                    "facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3017)",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "state": "Hubei",
                    "zip": "430010",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+8615871725926"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "The First Affiliated Hospital of Nanchang University ( Site 3004)",
                    "status": "RECRUITING",
                    "city": "Nanchang",
                    "state": "Jiangxi",
                    "zip": "330006",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+8613970053600"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.68396,
                        "lon": 115.85306
                    }
                },
                {
                    "facility": "Jiangxi Provincial Cancer Hospital ( Site 3005)",
                    "status": "RECRUITING",
                    "city": "Nanchang",
                    "state": "Jiangxi",
                    "zip": "330029",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "86 13607045741"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.68396,
                        "lon": 115.85306
                    }
                },
                {
                    "facility": "centre hospitalier lyon sud-Service H\u00e9matologie ( Site 0702)",
                    "status": "RECRUITING",
                    "city": "Pierre-B\u00e9nite",
                    "state": "Rhone",
                    "zip": "69310",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33478864348"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "Pitie Salpetriere University Hospital-Clinical haematology ( Site 0700)",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75013",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33142162330"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Emek Medical Center-Hematology Unit ( Site 1102)",
                    "status": "RECRUITING",
                    "city": "Afula",
                    "zip": "1834111",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "972-4-6494033"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.60907,
                        "lon": 35.2892
                    }
                },
                {
                    "facility": "Carmel Hospital ( Site 1103)",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "3436212",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97248250844"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah Medical Center ( Site 1100)",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97226778243"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 1204)",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "state": "Lazio",
                    "zip": "00168",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0630154180"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1203)",
                    "status": "RECRUITING",
                    "city": "Rozzano",
                    "state": "Milano",
                    "zip": "20089",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0282244080"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.38193,
                        "lon": 9.1559
                    }
                },
                {
                    "facility": "IRCCS - AOU di Bologna-Istituto di Ematologia \"L. e A. Seragnoli\" ( Site 1200)",
                    "status": "COMPLETED",
                    "city": "Bologna",
                    "zip": "40138",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1202)",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "390815903382"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Seoul National University Hospital-Oncology ( Site 0302)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82220723559"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center ( Site 0300)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82-2-3410-6548"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site",
                    "status": "COMPLETED",
                    "city": "Wroclaw",
                    "state": "Dolnoslaskie",
                    "zip": "50-367",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.1,
                        "lon": 17.03333
                    }
                },
                {
                    "facility": "Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologiczny ( Site 1304)",
                    "status": "RECRUITING",
                    "city": "Lublin",
                    "state": "Lubelskie",
                    "zip": "20-090",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0048 609 729 349"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.25,
                        "lon": 22.56667
                    }
                },
                {
                    "facility": "Pratia MCM Krakow ( Site 1303)",
                    "status": "RECRUITING",
                    "city": "Krakow",
                    "state": "Malopolskie",
                    "zip": "30-727",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0048602338290"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.06143,
                        "lon": 19.93658
                    }
                },
                {
                    "facility": "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotwor\u00f3w Uk\u0142adu Ch\u0142onnego ( S",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "state": "Mazowieckie",
                    "zip": "02-781",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0048225462366"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Szpitale Pomorskie Sp. z o. o.-Hematology and Bone Marrow Transplantation Department ( Site 1302)",
                    "status": "COMPLETED",
                    "city": "Gdynia",
                    "state": "Pomorskie",
                    "zip": "81-519",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.51889,
                        "lon": 18.53188
                    }
                },
                {
                    "facility": "Maharaj Nakorn Chiang Mai Hospital ( Site 0401)",
                    "status": "RECRUITING",
                    "city": "Muang",
                    "state": "Chiang Mai",
                    "zip": "50200",
                    "country": "Thailand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+66-826949794"
                        }
                    ]
                },
                {
                    "facility": "Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 0400)",
                    "status": "RECRUITING",
                    "city": "Bangkok",
                    "state": "Krung Thep Maha Nakhon",
                    "zip": "10700",
                    "country": "Thailand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+66840114290"
                        }
                    ],
                    "geoPoint": {
                        "lat": 13.75398,
                        "lon": 100.50144
                    }
                },
                {
                    "facility": "Ege University Medicine of Faculty ( Site 1902)",
                    "status": "RECRUITING",
                    "city": "Bornova",
                    "state": "Izmir",
                    "zip": "35100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+905325566128"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.47921,
                        "lon": 27.2399
                    }
                },
                {
                    "facility": "Ankara University Hospital Cebeci-hematology ( Site 1901)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+90 505 502 50 50"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Mega Medipol-Hematology ( Site 1909)",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34214",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905437870708"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Dokuz Eyl\u00fcl \u00dcniversitesi-Hematology ( Site 1905)",
                    "status": "RECRUITING",
                    "city": "Izmir",
                    "zip": "35340",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+905425151780"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                },
                {
                    "facility": "Ondokuz May\u0131s Universitesi ( Site 1907)",
                    "status": "COMPLETED",
                    "city": "Samsun",
                    "zip": "55139",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.27976,
                        "lon": 36.3361
                    }
                },
                {
                    "facility": "University College London Hospital-Cancer Clinical Trials Unit ( Site 2100)",
                    "status": "RECRUITING",
                    "city": "London-Camden",
                    "state": "London, City Of",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "07877274114"
                        }
                    ]
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=2140-003&&kw=2140-003"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000016393",
                    "term": "Lymphoma, B-Cell"
                },
                {
                    "id": "D000016403",
                    "term": "Lymphoma, Large B-Cell, Diffuse"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18831",
                    "name": "Lymphoma, Large B-Cell, Diffuse",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "asFound": "B-cell Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1866",
                    "name": "Diffuse Large B-Cell Lymphoma",
                    "asFound": "Diffuse Large B-Cell Lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069283",
                    "term": "Rituximab"
                },
                {
                    "id": "D000093542",
                    "term": "Gemcitabine"
                },
                {
                    "id": "D000077150",
                    "term": "Oxaliplatin"
                },
                {
                    "id": "D000069461",
                    "term": "Bendamustine Hydrochloride"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2985",
                    "name": "Gemcitabine",
                    "asFound": "Mg/kg",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "asFound": "Min",
                    "relevance": "HIGH"
                },
                {
                    "id": "M430",
                    "name": "Bendamustine Hydrochloride",
                    "asFound": "Inserted",
                    "relevance": "HIGH"
                },
                {
                    "id": "M373",
                    "name": "Rituximab",
                    "asFound": "Infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                }
            ]
        }
    },
    "hasResults": false
}